Podcast | Biopharma Beat: Global Travels, AI Deep Dives & Brain Shuttles

Research evidence excerpt

Podcast | Biopharma Beat: Global Travels, AI Deep Dives & Brain Shuttles

search analyst's household.

Morgan Stanley & Co. LLC makes a market in the securities of 10X Genomics Inc, 4D Molecular Therapeutics Inc, ABSCI CORP, Acadia Pharmaceuticals Inc, Adaptive Biotechnologies Corp., Agilent

Technologies, Inc., Alector Inc, Arcus Biosciences Inc., Arcutis Biotherapeutics, Inc., Arrowhead Pharmaceuticals Inc, Arvinas Inc, Avalyn Pharma Inc, Axsome Therapeutics, Belite Bio Inc, Bicara

Therapeutics, Bicycle Therapeutics Plc, BioAge Labs Inc, Biohaven Ltd, BridgeBio Oncology Therapeutics, Celldex Therapeutics Inc, Centessa Pharmaceuticals, Inc, CG Oncology, Charles River

Laboratories International, Compass Pathways PLC, Crinetics Pharmaceuticals, Cullinan Therapeutics, Cytek Biosciences Inc., Denali Therapeutics Inc, Disc Medicine Inc, Dyne Therapeutics Inc,

Generate Biomedicines Inc, Guardant Health Inc., Immunocore Holdings Ltd, Intellia Therapeutics Inc, Kalaris Therapeutics, Kymera Therapeutics Inc, Kyverna Therapeutics, MapLight

Therapeutics, Mettler-Toledo International Inc, Mirum Pharmaceuticals, Nurix Therapeutics Inc., Organon & Co., Personalis Inc, Pharvaris N.V., PTC Therapeutics, Regeneron Pharmaceuticals

Inc., Regenxbio Inc, Resmed Inc, Rhythm Pharmaceuticals Inc, Rocket Pharmaceuticals Inc, Sana Biotechnology, Inc, Schrodinger Inc., Silence Therapeutics Plc, Trevi Therapeutics Inc, Tscan

Therapeutics Inc, Ultragenyx Pharmaceutical Inc, Veracyte Inc, Vir Biotechnology Inc, Waters Corporation, West Pharmaceutical Services Inc., Zenas Biopharma Inc, Zentalis Pharmaceuticals

Inc.

The equity research analysts or strategists principally responsible for the preparation of Morgan Stanley Research have received compensation based upon various factors, including quality